Roman Herout
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Roman Herout has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Christian Thomas
Department of Urology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany
6 shared publications- Ben Hall Chew
Department of Urology, University of British Columbia, Vancouver, Canada
5 shared publications Martin Baunacke
Department of Urology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany
5 shared publicationsAngelika Borkowetz
4 shared publications- Dirk Lange
Department of Urologic Sciences, University of British Columbia, Vancouver, Canada
4 shared publications Johannes Huber
Department of Urology, University Hospital Heidelberg, Heidelberg, Germany
4 shared publications
Latest Publications
- 10 November 2026
- Published by Springer Nature in Die Urologie
- p. 1-10
Die retroperitoneale Fibrose (Morbus Ormond)
- 10 November 2026
- Published by Springer Nature in Die Urologie
- p. 1-10
Die retroperitoneale Fibrose (Morbus Ormond)
- 19 May 2026
- Published by Springer Nature in Die Urologie
- Vol. 65 (7) , 749-755
Rezidivierende Urolithiasis – Wann Therapie eskalieren? Wann absetzen?
Urolithiasis is a common condition characterized by a high recurrence rate and substantial clinical and economic impact. Stone formers are stratified into low- and high-risk groups based on stone analysis and basic diagnostic evaluation. Following a stone event (spontaneous passage or interventional treatment), all patients should receive general preventive measures, including increased fluid intake, dietary modification, and lifestyle changes. High-risk patients should additionally undergo extended metabolic evaluation (24 h urine analysis) and, if indicated, targeted pharmacological therapy. Therapeutic escalation is warranted in cases of recurrent stone formation, persistent metabolic abnormalities in 24 h urine, or high-risk stone types (e.g., brushite, cystine). The primary aim is correction of pathological urinary parameters by reducing lithogenic factors (calcium, oxalate, uric acid) and increasing inhibitors of stone formation (citrate, magnesium). Pharmacological treatment mainly includes alkaline citrates, thiazides, and xanthine oxidase inhibitors, initiated at low doses and adjusted according to urinary and, if necessary, serum parameters. Therapy de-escalation or discontinuation may be considered in patients with sustained stone-free status and stable metabolic findings, considering age, recurrence dynamics, and comorbidities (particularly hypertension, diabetes, and obesity). Individualized management in interdisciplinary collaboration with nephrology, primary care, and nutritional medicine is essential, as urolithiasis should be regarded as a complex metabolic disorder. Patient adherence remains a key determinant of long-term therapeutic success.
- 19 May 2026
- Published by Springer Nature in Die Urologie
- Vol. 65 (7) , 749-755
Rezidivierende Urolithiasis – Wann Therapie eskalieren? Wann absetzen?
Urolithiasis is a common condition characterized by a high recurrence rate and substantial clinical and economic impact. Stone formers are stratified into low- and high-risk groups based on stone analysis and basic diagnostic evaluation. Following a stone event (spontaneous passage or interventional treatment), all patients should receive general preventive measures, including increased fluid intake, dietary modification, and lifestyle changes. High-risk patients should additionally undergo extended metabolic evaluation (24 h urine analysis) and, if indicated, targeted pharmacological therapy. Therapeutic escalation is warranted in cases of recurrent stone formation, persistent metabolic abnormalities in 24 h urine, or high-risk stone types (e.g., brushite, cystine). The primary aim is correction of pathological urinary parameters by reducing lithogenic factors (calcium, oxalate, uric acid) and increasing inhibitors of stone formation (citrate, magnesium). Pharmacological treatment mainly includes alkaline citrates, thiazides, and xanthine oxidase inhibitors, initiated at low doses and adjusted according to urinary and, if necessary, serum parameters. Therapy de-escalation or discontinuation may be considered in patients with sustained stone-free status and stable metabolic findings, considering age, recurrence dynamics, and comorbidities (particularly hypertension, diabetes, and obesity). Individualized management in interdisciplinary collaboration with nephrology, primary care, and nutritional medicine is essential, as urolithiasis should be regarded as a complex metabolic disorder. Patient adherence remains a key determinant of long-term therapeutic success.
- Open Access
- 28 April 2025
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57 (11) , 3559-3565
Increasing utilization of urethroplasty for male urethral stricture disease: analysis of in-hospital interventions in Germany from 2006 to 2023
Purpose: There is a wide range of surgical treatments for urethral strictures. There is no information on the extent to which these procedures have been used over the past few years. Methods: We analyzed data from Diagnosis Related Groups (DRG) billing data from DESTATIS. Linear regression models were utilized for the analysis of trends over time. Results: A significant decrease of male urethral stricture cases during the study period was observed. Cases decreased from 48,020 cases in 2006 to 33,062 cases in 2023, i.e. -31%. This decline was mainly driven by the decrease in cases in the younger age group (≤ 79 years), whereas a significant increase was noted in octogenarians (+ 24%). A total of 834,476 procedures for urethral stricture disease were analyzed. In accordance with total case numbers, inpatient surgical interventions for urethral stricture disease decreased by 39% during the study period. Internal urethrotomy significantly decreased by 50% (from 41,443 in 2006 to 20,777 in 2023; p < 0.001). Likewise, urethral dilatations significantly decreased by 17% (from 14,134 in 2006 to 11,674 in 2023; p = 0.002). On the contrary, urethroplasties significantly increased by 156% (from 873 in 2006 to 2,239 in 2023; p < 0.001). Conclusion: We present contemporary data on urethral stricture disease management in Germany. Case numbers of internal urethrotomies and urethral dilatations are declining while urethroplasty is increasingly utilized as a definitive treatment for urethral stricture disease. This may reflect an optimized treatment of urethral strictures with more urethroplasties and thus fewer relapses to be treated.
- 28 April 2025
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57 (11) , 3559-3565
Open AccessIncreasing utilization of urethroplasty for male urethral stricture disease: analysis of in-hospital interventions in Germany from 2006 to 2023
Purpose: There is a wide range of surgical treatments for urethral strictures. There is no information on the extent to which these procedures have been used over the past few years. Methods: We analyzed data from Diagnosis Related Groups (DRG) billing data from DESTATIS. Linear regression models were utilized for the analysis of trends over time. Results: A significant decrease of male urethral stricture cases during the study period was observed. Cases decreased from 48,020 cases in 2006 to 33,062 cases in 2023, i.e. -31%. This decline was mainly driven by the decrease in cases in the younger age group (≤ 79 years), whereas a significant increase was noted in octogenarians (+ 24%). A total of 834,476 procedures for urethral stricture disease were analyzed. In accordance with total case numbers, inpatient surgical interventions for urethral stricture disease decreased by 39% during the study period. Internal urethrotomy significantly decreased by 50% (from 41,443 in 2006 to 20,777 in 2023; p < 0.001). Likewise, urethral dilatations significantly decreased by 17% (from 14,134 in 2006 to 11,674 in 2023; p = 0.002). On the contrary, urethroplasties significantly increased by 156% (from 873 in 2006 to 2,239 in 2023; p < 0.001). Conclusion: We present contemporary data on urethral stricture disease management in Germany. Case numbers of internal urethrotomies and urethral dilatations are declining while urethroplasty is increasingly utilized as a definitive treatment for urethral stricture disease. This may reflect an optimized treatment of urethral strictures with more urethroplasties and thus fewer relapses to be treated.
- 12 March 2025
- Published by Georg Thieme Verlag KG in Aktuelle Urologie
- Vol. 56 (02) , 145-149
Geschlechtsspezifische Unterschiede der Harnsteinerkrankung unter Beachtung des Oxalatstoffwechsels der Leber
Zusammenfassung: In den Industrienationen nimmt die Inzidenz und Prävalenz der Harnsteinerkrankung zu. Ein Anstieg wird vor allem bei jungen Erwachsenen und Frauen beobachtet. Die Verteilung zwischen den Geschlechtern (historisch 3:1) gleicht sich immer mehr an. Für die USA wurde bereits ein Geschlechtergleichstand (1:1) dokumentiert. Frauen weisen in Studien im Vergleich zu Männern höhere Urin-pH-Werte auf, die eine Kalziumphosphatkristallisation begünstigen. Die bevorzugte Kalziumoxalat- und Harnsäuresteinbildung bei Männern wird durch die im Vergleich niedrigeren Urin-pH-Werte hervorgerufen. Die Fehlernährung in Kombination mit Bewegungsmangel und dem vermehrten Auftreten des metabolischen Syndroms mit den zugrunde liegenden Erkrankungen (Insulinresistenz, Diabetes mellitus Typ 2, Adipositas, Dyslipidämie) wird als Ursache der Zunahme der Harnsteinerkrankung in den Industrieländern diskutiert. Zu den Folgeerkrankungen des metabolischen Syndroms wird die nicht-alkoholische Leberverfettung (NAFLD) als häufigste Lebererkrankung mit einer Prävalenz von ca. 23% in Deutschland gezählt. Tierexperimentelle und klinische Untersuchungen konnten einen Zusammenhang zwischen der NAFLD und einer erhöhten Oxalsäureausscheidung im Urin nachweisen. In Kenntnis der Literatur stellt die NAFLD einen möglichen, geschlechterübergreifenden Risikofaktor der Harnsteinbildung dar und gerät somit in das Blickfeld der allgemein modifizierbaren Risikofaktoren der rezidivierenden Harnsteinerkrankung. Einfache, die NAFLD betreffende Empfehlungen sollten die allgemeine Steinmetaphylaxe im klinischen Alltag erweitern.
- 12 March 2025
- Published by Georg Thieme Verlag KG in Aktuelle Urologie
- Vol. 56 (02) , 145-149
Geschlechtsspezifische Unterschiede der Harnsteinerkrankung unter Beachtung des Oxalatstoffwechsels der Leber
Zusammenfassung: In den Industrienationen nimmt die Inzidenz und Prävalenz der Harnsteinerkrankung zu. Ein Anstieg wird vor allem bei jungen Erwachsenen und Frauen beobachtet. Die Verteilung zwischen den Geschlechtern (historisch 3:1) gleicht sich immer mehr an. Für die USA wurde bereits ein Geschlechtergleichstand (1:1) dokumentiert. Frauen weisen in Studien im Vergleich zu Männern höhere Urin-pH-Werte auf, die eine Kalziumphosphatkristallisation begünstigen. Die bevorzugte Kalziumoxalat- und Harnsäuresteinbildung bei Männern wird durch die im Vergleich niedrigeren Urin-pH-Werte hervorgerufen. Die Fehlernährung in Kombination mit Bewegungsmangel und dem vermehrten Auftreten des metabolischen Syndroms mit den zugrunde liegenden Erkrankungen (Insulinresistenz, Diabetes mellitus Typ 2, Adipositas, Dyslipidämie) wird als Ursache der Zunahme der Harnsteinerkrankung in den Industrieländern diskutiert. Zu den Folgeerkrankungen des metabolischen Syndroms wird die nicht-alkoholische Leberverfettung (NAFLD) als häufigste Lebererkrankung mit einer Prävalenz von ca. 23% in Deutschland gezählt. Tierexperimentelle und klinische Untersuchungen konnten einen Zusammenhang zwischen der NAFLD und einer erhöhten Oxalsäureausscheidung im Urin nachweisen. In Kenntnis der Literatur stellt die NAFLD einen möglichen, geschlechterübergreifenden Risikofaktor der Harnsteinbildung dar und gerät somit in das Blickfeld der allgemein modifizierbaren Risikofaktoren der rezidivierenden Harnsteinerkrankung. Einfache, die NAFLD betreffende Empfehlungen sollten die allgemeine Steinmetaphylaxe im klinischen Alltag erweitern.
- Open Access
- 17 February 2025
- Published by S. Karger AG in Urologia Internationalis
- Vol. 109 (5) , 487-493
Surgical Preferences and Fears: Misconceptions about Robotic-Assisted Surgery
Introduction and Objective: Robotic-assisted surgery (RAS) is widely adopted across surgical fields, notably urology, but patient knowledge remains limited, often shaped by misconceptions. Previous research indicates factors like age, profession, and technology use influence RAS perceptions. This study investigates public knowledge, preferences, and misconceptions about RAS within a German cohort. Methods: A cross-sectional survey at a university hospital’s open house gathered responses from 339 participants prior to an RAS exhibition. The questionnaire assessed demographics, surgical preferences, and RAS knowledge. Statistical analyses, including t tests, chi-squared tests, ANOVA, and multivariate logistic regression, identified key associations. Results: A total of 71% (234) of participants favored RAS over conventional surgery, yet misconceptions persisted in 38% (122), particularly among pensioners (48% (46), p < 0.01). Misconceptions were linked to a preference for conventional surgery (43% (52) vs. 19% (36), p < 0.01). Surgical preference emerged as a significant predictor of misconception. Concerns included surgeon skill (41%, 141) and machine malfunction (39%, 132), with younger participants fearing human error and older individuals fearing technical failure (p < 0.01). Conclusion: This local study reveals strong public support for RAS but underscores prevalent misconceptions, especially among older adults, suggesting that addressing misconceptions could foster acceptance and informed decision-making.
- 17 February 2025
- Published by S. Karger AG in Urologia Internationalis
- Vol. 109 (5) , 487-493
Open AccessSurgical Preferences and Fears: Misconceptions about Robotic-Assisted Surgery
Introduction and Objective: Robotic-assisted surgery (RAS) is widely adopted across surgical fields, notably urology, but patient knowledge remains limited, often shaped by misconceptions. Previous research indicates factors like age, profession, and technology use influence RAS perceptions. This study investigates public knowledge, preferences, and misconceptions about RAS within a German cohort. Methods: A cross-sectional survey at a university hospital’s open house gathered responses from 339 participants prior to an RAS exhibition. The questionnaire assessed demographics, surgical preferences, and RAS knowledge. Statistical analyses, including t tests, chi-squared tests, ANOVA, and multivariate logistic regression, identified key associations. Results: A total of 71% (234) of participants favored RAS over conventional surgery, yet misconceptions persisted in 38% (122), particularly among pensioners (48% (46), p < 0.01). Misconceptions were linked to a preference for conventional surgery (43% (52) vs. 19% (36), p < 0.01). Surgical preference emerged as a significant predictor of misconception. Concerns included surgeon skill (41%, 141) and machine malfunction (39%, 132), with younger participants fearing human error and older individuals fearing technical failure (p < 0.01). Conclusion: This local study reveals strong public support for RAS but underscores prevalent misconceptions, especially among older adults, suggesting that addressing misconceptions could foster acceptance and informed decision-making.
- Open Access
- 29 November 2024
- Published by S. Karger AG in Urologia Internationalis
- Vol. 109 (3) , 244-250
Focus on the Blind Spot of Stone Disease: Analysis of Lower Urinary Tract Stone Interventions from 2006 to 2020 Using German Nationwide Inpatient Data
Introduction: The aim of the study was to analyze contemporary treatment trends in bladder stone management in Germany over a 15-year period. Methods: We analyzed data from the nationwide German hospital billing database from 2006 to 2020. The significance of changes over time was evaluated via linear regression analysis. Results: Total case numbers of therapeutic interventions for lower urinary tract calculi increased from 6,770 in 2006 to 9,037 in 2020 (p < 0.001). Transurethral cystolithotripsy (TUCL) was the predominant procedure with increasing case numbers from 5,552 in 2006 to 7,699 in 2020 (p < 0.001). Also, the share of TUCL increased by 4% during the study period. TUCL with laser fragmentation was coded in 82 cases in 2006 and in 1,527 cases in 2020 (p < 0.001). Case numbers of percutaneous cystolithotripsy also increased over time from 406 to 430 cases (p = 0.005), but the share decreased by 20%. Inpatient shock wave lithotripsy is very rarely performed for bladder calculi with an average of 22 cases per year in all hospitals in Germany. Case numbers of open cystolithotomy (OCL) also increased from 614 cases in 2006 to 692 cases in 2020 (p = 0.006), but the share decreased by 15.5%. On average, 164 cases of stone removal from neobladders per year were performed, mainly transurethrally (47%) or via an open approach (21%). Case numbers of TUCL combined with transurethral resection of the prostate (TUR-P) declined from 1,712 in 2006 to 1,450 in 2020 (p = 0.014). However, this might be attributed to the concomitant rise of laser enucleation of the prostate with steadily increasing case numbers in Germany. Conclusion: We present contemporary population-based data on bladder stone treatment in Germany. TUCL is the predominant therapeutic modality with increasing case numbers, but OCL is still performed frequently. TUR-P is the procedure that is most often combined with TUCL.
- 29 November 2024
- Published by S. Karger AG in Urologia Internationalis
- Vol. 109 (3) , 244-250
Open AccessFocus on the Blind Spot of Stone Disease: Analysis of Lower Urinary Tract Stone Interventions from 2006 to 2020 Using German Nationwide Inpatient Data
Introduction: The aim of the study was to analyze contemporary treatment trends in bladder stone management in Germany over a 15-year period. Methods: We analyzed data from the nationwide German hospital billing database from 2006 to 2020. The significance of changes over time was evaluated via linear regression analysis. Results: Total case numbers of therapeutic interventions for lower urinary tract calculi increased from 6,770 in 2006 to 9,037 in 2020 (p < 0.001). Transurethral cystolithotripsy (TUCL) was the predominant procedure with increasing case numbers from 5,552 in 2006 to 7,699 in 2020 (p < 0.001). Also, the share of TUCL increased by 4% during the study period. TUCL with laser fragmentation was coded in 82 cases in 2006 and in 1,527 cases in 2020 (p < 0.001). Case numbers of percutaneous cystolithotripsy also increased over time from 406 to 430 cases (p = 0.005), but the share decreased by 20%. Inpatient shock wave lithotripsy is very rarely performed for bladder calculi with an average of 22 cases per year in all hospitals in Germany. Case numbers of open cystolithotomy (OCL) also increased from 614 cases in 2006 to 692 cases in 2020 (p = 0.006), but the share decreased by 15.5%. On average, 164 cases of stone removal from neobladders per year were performed, mainly transurethrally (47%) or via an open approach (21%). Case numbers of TUCL combined with transurethral resection of the prostate (TUR-P) declined from 1,712 in 2006 to 1,450 in 2020 (p = 0.014). However, this might be attributed to the concomitant rise of laser enucleation of the prostate with steadily increasing case numbers in Germany. Conclusion: We present contemporary population-based data on bladder stone treatment in Germany. TUCL is the predominant therapeutic modality with increasing case numbers, but OCL is still performed frequently. TUR-P is the procedure that is most often combined with TUCL.
- 1 November 2023
- Published by SAGE Publications in Journal of Endourology
- Vol. 37 (11) , 1200-1208
Intrarenal Pressure Measured Using a Novel Flexible Ureteroscope with Pressure Sensing Capabilities: A Study of the Effects of Ureteral Access Sheath, Irrigation, and Working Channel Accessories
Introduction: Intrarenal pressure is emerging as an important monitoring parameter during flexible ureteroscopy (fURS). We measure how intraoperative conditions affect intrarenal pressure using a novel pressure sensing ureteroscope. Methods: The LithoVue Elite (LVE) single-use digital flexible ureteroscope (Boston Scientific) is the first commercial ureteroscope that senses pressure at its tip. LVE was used in a porcine model to measure intrarenal pressure with and without a ureteral access sheath (UAS) with various sizes and placement locations, irrigation methods, and working channel accessories. LVE pressure accuracy was measured in a bench model. This abstract shows the least-square means from multiway analysis of variances used for analysis. Results: Intrarenal pressures were the highest without a UAS (64 mm Hg), followed by the 11/13 UAS (51 mm Hg) and the 12/14 and 13/15, which were not statistically different (39–40 mm Hg). The pressures were highest with UASs placed at the ureteropelvic junction (61 mm Hg), and lowest if placed in the renal pelvis (24 mm Hg). Irrigation methods showed the highest pressures with syringe (57 mm Hg), while irrigation bags (pressurized at 150–300 mm Hg) produced 43 to 46 mm Hg and 25 mm Hg when applied with 80 cm of gravity. Placing a 200 μm laser fiber reduced pressures from 44 to 41 mm Hg. Finally, the bench model showed that LVE was 96% accurate up to 300 mm Hg. Conclusion: Intrarenal pressure significantly varied based on UAS sizes, placement, and irrigation methods. Accordingly, fURS with LVE is poised to be an invaluable tool for clinical decision-making and future studies of intrarenal pressure.
- 1 November 2023
- Published by SAGE Publications in Journal of Endourology
- Vol. 37 (11) , 1200-1208
Intrarenal Pressure Measured Using a Novel Flexible Ureteroscope with Pressure Sensing Capabilities: A Study of the Effects of Ureteral Access Sheath, Irrigation, and Working Channel Accessories
Introduction: Intrarenal pressure is emerging as an important monitoring parameter during flexible ureteroscopy (fURS). We measure how intraoperative conditions affect intrarenal pressure using a novel pressure sensing ureteroscope. Methods: The LithoVue Elite (LVE) single-use digital flexible ureteroscope (Boston Scientific) is the first commercial ureteroscope that senses pressure at its tip. LVE was used in a porcine model to measure intrarenal pressure with and without a ureteral access sheath (UAS) with various sizes and placement locations, irrigation methods, and working channel accessories. LVE pressure accuracy was measured in a bench model. This abstract shows the least-square means from multiway analysis of variances used for analysis. Results: Intrarenal pressures were the highest without a UAS (64 mm Hg), followed by the 11/13 UAS (51 mm Hg) and the 12/14 and 13/15, which were not statistically different (39–40 mm Hg). The pressures were highest with UASs placed at the ureteropelvic junction (61 mm Hg), and lowest if placed in the renal pelvis (24 mm Hg). Irrigation methods showed the highest pressures with syringe (57 mm Hg), while irrigation bags (pressurized at 150–300 mm Hg) produced 43 to 46 mm Hg and 25 mm Hg when applied with 80 cm of gravity. Placing a 200 μm laser fiber reduced pressures from 44 to 41 mm Hg. Finally, the bench model showed that LVE was 96% accurate up to 300 mm Hg. Conclusion: Intrarenal pressure significantly varied based on UAS sizes, placement, and irrigation methods. Accordingly, fURS with LVE is poised to be an invaluable tool for clinical decision-making and future studies of intrarenal pressure.
- Open Access
- 24 August 2023
- Published by Springer Nature in International Urology and Nephrology
- Vol. 55 (12) , 3039-3044
Emergency treatment of symptomatic ureteral calculi: predictors of prolonged hospital stay
Purpose: To assess differences in the length of hospital stay (LOS) in patients who present emergently versus electively for a symptomatic ureteral stone and to explore underlying risk factors. Methods: Billing data were analyzed from patients with symptomatic ureteral calculi at our department from 2010 to 2021. Statistical analysis (U test, logistic regression) was performed. Results: 2274 patients (72% male, 28% female) with ureteral stones were analyzed (mean age of 52.9y). 1578 patients (69.4%) presented in an emergency setting and 696 patients (30.6%) electively. Arterial hypertension was seen in 31%, diabetes mellitus in 11% and hyperuricemia in 5% of the whole cohort. 46.5% of emergency patients were desobstructed (DJ/PCN), 35.4% underwent emergency ureteroscopy (URS), 13.4% had spontaneous passage (SP), and 4.8% underwent emergency shock wave lithotripsy (SWL). Of the electively treated patients, 58.6% underwent URS, 21.3% SWL, 18.5% DJ/PCN, and 1.6% had SP. Emergency stone treatment was associated with a significantly longer LOS when compared to primary desobstruction for patients admitted emergently. Also, LOS was significantly longer for each intervention of stone treatment in emergency patients vs. electively treated patients. Arterial hypertension was associated with a 1.8-fold increased risk of a hospital stay longer than 3 days, irrespective of hospital admission mode, whereas metabolic disorders did not influence LOS in this cohort. Conclusion: For emergency patients in contrast to the electively treated patients, the type of procedure had a significant impact on the length of hospital stay. Arterial hypertension is an independent significant risk factor for prolonged hospital stay.
- 24 August 2023
- Published by Springer Nature in International Urology and Nephrology
- Vol. 55 (12) , 3039-3044
Open AccessEmergency treatment of symptomatic ureteral calculi: predictors of prolonged hospital stay
Purpose: To assess differences in the length of hospital stay (LOS) in patients who present emergently versus electively for a symptomatic ureteral stone and to explore underlying risk factors. Methods: Billing data were analyzed from patients with symptomatic ureteral calculi at our department from 2010 to 2021. Statistical analysis (U test, logistic regression) was performed. Results: 2274 patients (72% male, 28% female) with ureteral stones were analyzed (mean age of 52.9y). 1578 patients (69.4%) presented in an emergency setting and 696 patients (30.6%) electively. Arterial hypertension was seen in 31%, diabetes mellitus in 11% and hyperuricemia in 5% of the whole cohort. 46.5% of emergency patients were desobstructed (DJ/PCN), 35.4% underwent emergency ureteroscopy (URS), 13.4% had spontaneous passage (SP), and 4.8% underwent emergency shock wave lithotripsy (SWL). Of the electively treated patients, 58.6% underwent URS, 21.3% SWL, 18.5% DJ/PCN, and 1.6% had SP. Emergency stone treatment was associated with a significantly longer LOS when compared to primary desobstruction for patients admitted emergently. Also, LOS was significantly longer for each intervention of stone treatment in emergency patients vs. electively treated patients. Arterial hypertension was associated with a 1.8-fold increased risk of a hospital stay longer than 3 days, irrespective of hospital admission mode, whereas metabolic disorders did not influence LOS in this cohort. Conclusion: For emergency patients in contrast to the electively treated patients, the type of procedure had a significant impact on the length of hospital stay. Arterial hypertension is an independent significant risk factor for prolonged hospital stay.
- 9 May 2023
- Published by SAGE Publications in Journal of Endourology
- Vol. 37 (7) , 753-760
Innovations in Endourologic Stone Surgery: Contemporary Practice Patterns from a Global Survey
Objective: The purpose of this study is to evaluate the current availability of technology for urolithiasis treatment and ureteroscopy. Perioperative practice patterns, availability of ureteroscopic technologies, pre- and post-stenting practices, and methods to alleviate stent-related symptoms were assessed via a survey of members of the Endourological Society. Methods We distributed a 43-question survey online via the Qualtrics platform to members of the Endourological Society. The survey consisted of questions pertaining to the following topics: general (6), equipment (17), preoperative ureteroscopy (URS; 9), intraoperative URS (2), and postoperative URS (9). Results A total of 191 urologists responded to the survey. 51% of urologists were fellowship trained and dedicated an average of 58% of their practice to stone management. In terms of procedures, most urologists performed ureteroscopy most commonly (68%), followed by percutaneous nephrolithotomy (23%) and shockwave lithotripsy (11%). 90% of respondent urologists purchased a new ureteroscope within the last five years (16% single-use scopes, 53% reusable, and 31% purchased both). 57% of the respondents stated that they would be interested in a ureteroscope that can sense intrarenal pressure, with an additional 30% stating they would be interested depending on the cost. 80% of responders purchased a new laser within the last five years, and 59% changed their lasering technique due to the new laser. 70% are performing primary ureteroscopy for obstructing stones, and 30% prefer pre-stenting patients for subsequent URS (on average after 21 days). 59% of responders insert a ureteral stent after URS, which is removed, on average, after eight days in uncomplicated cases and 21 days after complicated URS. Most urologists give analgesics, alpha-blockers, and anticholinergics for stent-related symptoms and less than 10% prescribe opioids. Conclusion Our survey revealed urologists’ eagerness for the early adoption of novel technologies and adherence to conservative practice patterns focused on patient safety.
- 9 May 2023
- Published by SAGE Publications in Journal of Endourology
- Vol. 37 (7) , 753-760
Innovations in Endourologic Stone Surgery: Contemporary Practice Patterns from a Global Survey
Objective: The purpose of this study is to evaluate the current availability of technology for urolithiasis treatment and ureteroscopy. Perioperative practice patterns, availability of ureteroscopic technologies, pre- and post-stenting practices, and methods to alleviate stent-related symptoms were assessed via a survey of members of the Endourological Society. Methods We distributed a 43-question survey online via the Qualtrics platform to members of the Endourological Society. The survey consisted of questions pertaining to the following topics: general (6), equipment (17), preoperative ureteroscopy (URS; 9), intraoperative URS (2), and postoperative URS (9). Results A total of 191 urologists responded to the survey. 51% of urologists were fellowship trained and dedicated an average of 58% of their practice to stone management. In terms of procedures, most urologists performed ureteroscopy most commonly (68%), followed by percutaneous nephrolithotomy (23%) and shockwave lithotripsy (11%). 90% of respondent urologists purchased a new ureteroscope within the last five years (16% single-use scopes, 53% reusable, and 31% purchased both). 57% of the respondents stated that they would be interested in a ureteroscope that can sense intrarenal pressure, with an additional 30% stating they would be interested depending on the cost. 80% of responders purchased a new laser within the last five years, and 59% changed their lasering technique due to the new laser. 70% are performing primary ureteroscopy for obstructing stones, and 30% prefer pre-stenting patients for subsequent URS (on average after 21 days). 59% of responders insert a ureteral stent after URS, which is removed, on average, after eight days in uncomplicated cases and 21 days after complicated URS. Most urologists give analgesics, alpha-blockers, and anticholinergics for stent-related symptoms and less than 10% prescribe opioids. Conclusion Our survey revealed urologists’ eagerness for the early adoption of novel technologies and adherence to conservative practice patterns focused on patient safety.
- Open Access
Development of a High-Throughput Urosepsis Mouse Model
Murine sepsis models are typically polymicrobial, and are associated with high mortality. We aimed to develop a high-throughput murine model that mimics a slow-paced, monomicrobial sepsis originating from the urinary tract. A total of 23 male C57Bl/6 mice underwent percutaneous insertion of a 4 mm catheter into the bladder using an ultrasound-guided method, previously developed by our group. The following day, Proteus mirabilis (PM) was introduced percutaneously in the bladder in three groups: g1—50 µL 1 × 108 CFU/mL solution (n = 10); g2—50 µL 1 × 107 CFU/mL solution (n = 10); and g3 (sham mice)—50 µL sterile saline (n = 3). On day 4, mice were sacrificed. The number of planktonic bacteria in urine, adherent to catheters, and adherent to/invaded into the bladder and spleen was assessed. Cell-free DNA, D-dimer, thrombin–antithrombin complex (TAT), and 32 pro-/anti-inflammatory cytokines/chemokines were quantified in the blood. All mice survived the 4 day postinterventional period. Mean weight loss was 11% in g1, 9% in g2, and 3% in the control mice. Mean urine CFU counts were highest in group 1. All catheters showed high catheter-adhered bacterial counts. Of the infected mice, 17/20 had CFU counts in the splenic tissue, indicating septicemia. Plasma levels of cell-free DNA, D-dimer, and the proinflammatory cytokines IFN-γ, IL-6, IP-10, MIG, and G-CSF were significantly elevated in infected mice versus controls. We present a reproducible, monomicrobial murine model of urosepsis that does not lead to rapid deterioration and death, and is useful for studying prolonged urosepsis.
Open AccessDevelopment of a High-Throughput Urosepsis Mouse Model
Murine sepsis models are typically polymicrobial, and are associated with high mortality. We aimed to develop a high-throughput murine model that mimics a slow-paced, monomicrobial sepsis originating from the urinary tract. A total of 23 male C57Bl/6 mice underwent percutaneous insertion of a 4 mm catheter into the bladder using an ultrasound-guided method, previously developed by our group. The following day, Proteus mirabilis (PM) was introduced percutaneously in the bladder in three groups: g1—50 µL 1 × 108 CFU/mL solution (n = 10); g2—50 µL 1 × 107 CFU/mL solution (n = 10); and g3 (sham mice)—50 µL sterile saline (n = 3). On day 4, mice were sacrificed. The number of planktonic bacteria in urine, adherent to catheters, and adherent to/invaded into the bladder and spleen was assessed. Cell-free DNA, D-dimer, thrombin–antithrombin complex (TAT), and 32 pro-/anti-inflammatory cytokines/chemokines were quantified in the blood. All mice survived the 4 day postinterventional period. Mean weight loss was 11% in g1, 9% in g2, and 3% in the control mice. Mean urine CFU counts were highest in group 1. All catheters showed high catheter-adhered bacterial counts. Of the infected mice, 17/20 had CFU counts in the splenic tissue, indicating septicemia. Plasma levels of cell-free DNA, D-dimer, and the proinflammatory cytokines IFN-γ, IL-6, IP-10, MIG, and G-CSF were significantly elevated in infected mice versus controls. We present a reproducible, monomicrobial murine model of urosepsis that does not lead to rapid deterioration and death, and is useful for studying prolonged urosepsis.